Abstract
Over 60% of patients with hepatic cirrhosis develop ascites at some stage. Ascites is usually symptomatic and its continued presence predisposes to bacterial peritonitis. Complications of injudicious treatment can be life threatening.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Ascites / complications*
-
Ascites / diagnosis
-
Ascites / drug therapy
-
Ascites / physiopathology
-
Ascites / therapy
-
Diagnosis, Differential
-
Humans
-
Inhalation
-
Liver Cirrhosis / complications*
-
Peritonitis / complications
-
Spironolactone / therapeutic use
-
Triamterene / therapeutic use
Substances
-
Spironolactone
-
Triamterene